If I have to develop a Rotenone-induced Parkinson's model in the SH-SY5Y cell line, and further check the neuroprotective effect of my synthesized compound, does it really affect whether I treat my synthesized compound after or before rotenone treatment. My simple question is that the maximum number of papers suggest the pretreatment of a neuroprotective compound before treating with Rotenone for inducing PD in SH-SY5Y cells. What will happen if I treat Rotenone first before my synthesized compound?

More Samir Kumar Beura's questions See All
Similar questions and discussions